Cargando…
Neddylation of HER2 Inhibits its Protein Degradation and promotes Breast Cancer Progression
HER2 is a transmembrane receptor with intrinsic tyrosine kinase activity that is overexpressed in almost 25% of human breast cancers. Here, we report that the neddylation of HER2 is a new post-translational modification that controls its expression and oncogenic activity in human breast cancer. Two...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830515/ https://www.ncbi.nlm.nih.gov/pubmed/36632463 http://dx.doi.org/10.7150/ijbs.75852 |